rs121908032
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000527.5(LDLR):c.2439G>A(p.Trp813*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000527.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, familial, 1Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LDLR | NM_000527.5 | c.2439G>A | p.Trp813* | stop_gained | Exon 17 of 18 | ENST00000558518.6 | NP_000518.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Pathogenic:3
- -
- -
- -
not provided Pathogenic:1
The LDLR c.2439G>A p.Trp813Ter variant (rs121908032), also known as p.Trp792Ter in legacy nomenclature, is reported in the literature in multiple individuals affected with familial hypercholesterolaemia (selected references: Lehrman 1985, Loux 1991, Taylor 2007). This variant is reported in ClinVar (Variation ID: 3703) and is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. This variant induces an early termination codon in exon 17 (of 18) and truncates a critical cytoplasmic domain. This variant has been shown to greatly reduced LDL receptor activity (Lehrman 1985), and other nearby truncating variants, or deletions of exons 17-18 are considered disease causing (Jelassi 2009 and Alonso 2009). Based on available information, this variant is considered to be pathogenic. References: Alonso R et al. Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform. Clin Biochem. 2009 Jun;42(9):899-903. PMID: 19318025. Jelassi A et al. Limited mutational heterogeneity in the LDLR gene in familial hypercholesterolemia in Tunisia. Atherosclerosis. 2009 Apr;203(2):449-53. PMID: 18757057. Lehrman MA et al. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell. 1985 Jul;41(3):735-43. PMID: 3924410. Loux N et al. Recurrent mutation at aa 792 in the LDL receptor gene in a French patient. Hum Genet. 1991 Jul;87(3):373-5. PMID: 1677927. Taylor A et al. Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia. Clin Genet. 2007 Jun;71(6):561-8. PMID: 17539906. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at